Guido Dalbagni
Overview
Explore the profile of Guido Dalbagni including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
184
Citations
6139
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Makker S, Rammal R, Gu P, Dalbagni G, Al-Ahmadie H, Agaram N, et al.
Front Oncol
. 2025 Feb;
15:1508600.
PMID: 40018405
While gastrointestinal stromal tumors (GISTs) often arise within the GI tract, it is well known that GISTs may also rarely emanate outside of the digestive system. Prior case reports have...
2.
Lenis A, Whiting K, Ravichandran V, Tallman J, Alam S, Chu C, et al.
JCO Precis Oncol
. 2024 May;
8:e2300274.
PMID: 38691813
Purpose: Patients with residual invasive bladder cancer after neoadjuvant chemotherapy (NAC) and radical cystectomy have a poor prognosis. Data on adjuvant therapy for these patients are conflicting. We sought to...
3.
Katims A, Tallman J, Vertosick E, Porwal S, Dalbagni G, Cha E, et al.
JAMA Oncol
. 2024 Feb;
10(4):522-525.
PMID: 38358761
Importance: With the ongoing bacillus Calmette-Guèrin (BCG) shortage, alternate therapeutic options for patients with high-risk non-muscle-invasive bladder cancer (NMIBC) are needed. Objective: To report the 5-year outcomes of a cohort...
4.
Yip W, Assel M, Wong N, Tracey A, Alvim R, Nogueira L, et al.
Urol Pract
. 2024 Feb;
11(2):356-366.
PMID: 38315829
Introduction: We evaluated surgical trends, perioperative management evolution, and oncologic outcomes in patients who underwent radical nephroureterectomy (RNU) for upper tract urothelial carcinoma (UTUC) at a tertiary cancer center over...
5.
Katims A, Gaffney C, Firouzi S, Yip W, Aulitzky A, Pietzak E, et al.
Urol Oncol
. 2023 Aug;
41(10):433.e19-433.e24.
PMID: 37640571
Background: There is limited ability to accurately diagnose and clinically stage patients with upper tract urothelial carcinoma (UTUC). The most easily available and widely used urinary biomarker is urine cytology,...
6.
Yip W, Sjoberg D, Nogueira L, Tracey A, Alvim R, Reisz P, et al.
J Urol
. 2023 Feb;
209(5):863-871.
PMID: 36724067
Purpose: Vascular-targeted photodynamic therapy with the intravascular photosensitizing agent padeliporfin (WST-11/TOOKAD-Soluble) has demonstrated therapeutic efficacy as an ablative treatment for localized cancer with potential adaptation for endoscopic management of upper...
7.
Coleman J, Yip W, Wong N, Sjoberg D, Bochner B, Dalbagni G, et al.
J Clin Oncol
. 2023 Jan;
41(8):1618-1625.
PMID: 36603175
Purpose: Neoadjuvant chemotherapy (NAC) has proven survival benefits for patients with invasive urothelial carcinoma of the bladder, yet its role for upper tract urothelial carcinoma (UTUC) remains undefined. We conducted...
8.
Mano R, Hoeh B, DiNatale R, Sanchez A, Benfante N, Reznik E, et al.
Bladder Cancer
. 2022 Oct;
8(3):291-301.
PMID: 36277327
Background: Mucosal melanoma involving the urethra is a rare disease with distinct clinical and molecular characteristics and poor outcomes. Our current knowledge is limited by the small number of reports...
9.
Almassi N, Whiting K, Toubaji A, Lenis A, Jordan E, Won H, et al.
JCO Precis Oncol
. 2022 Jun;
6:e2100392.
PMID: 35731998
Purpose: To compare oncologic outcomes and genomic alteration profiles in patients with bladder and urachal adenocarcinoma, urothelial carcinoma (UC) with glandular differentiation, and UC, not otherwise specified (NOS) undergoing surgical...
10.
Huang C, Assel M, Beech B, Benfante N, Sjoberg D, Touijer A, et al.
BJU Int
. 2022 Jun;
130(6):809-814.
PMID: 35694836
Objectives: To analyse the risk of uretero-enteric anastomotic stricture in patients randomised to open (ORC) or robot-assisted radical cystectomy (RARC) with extracorporeal urinary diversion. Patients And Methods: We included 118...